Multimodal lifestyle intervention consistently improves cognition in early dementia

MedicalXpress | апр 22, 2026

For patients with early Alzheimer's disease and mild cognitive impairment, cognition is consistently improved with multimodal lifestyle interventions (MMLIs), while monoclonal antibodies (MABs) clear amyloid plaques but only modestly preserve cognition, according to research presented at the annual meeting of the American Academy of Neurology, held from April 18 to 22 in Chicago.